{"id":"oxyphenisatine","rwe":[{"pmid":"39787079","year":"2025","title":"Determination of oxyphenisatine and its total ester derivatives content in fermented green plum by ultra performance liquid chromatography-tandem mass spectrometry.","finding":"","journal":"Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment","studyType":"Clinical Study"},{"pmid":"20852860","year":"2011","title":"Novel small molecule drugs inhibit tumor cell metabolism and show potent anti-tumorigenic potential.","finding":"","journal":"Cancer chemotherapy and pharmacology","studyType":"Clinical Study"},{"pmid":"8136086","year":"1994","title":"Adverse effects of drugs used in the management of constipation and diarrhoea.","finding":"","journal":"Drug safety","studyType":"Clinical Study"},{"pmid":"6285673","year":"1982","title":"The action of six lipid perturbing substances on hormone receptor adenylate cyclase complex in turkey erythrocytes and intestinal mucosa cells.","finding":"","journal":"Acta pharmacologica et toxicologica","studyType":"Clinical Study"},{"pmid":"386256","year":"1979","title":"[Drug-induced active hepatitis (author's transl)].","finding":"","journal":"La Nouvelle presse medicale","studyType":"Clinical Study"}],"tags":[{"label":"oxyphenisatine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"A06AB01","category":"atc"},{"label":"Active","category":"status"},{"label":"Constipation","category":"indication"},{"label":"Cathartics","category":"pharmacology"},{"label":"Gastrointestinal Agents","category":"pharmacology"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=OXYPHENISATINE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:05:03.064263+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:05:08.511275+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=OXYPHENISATINE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:05:08.954068+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL245807/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:05:09.652985+00:00"}},"allNames":"veripaque","offLabel":[],"synonyms":["oxyphenisatin","oxyphenisatine","phenolisatin","veripaque"],"timeline":[],"brandName":"Veripaque","ecosystem":[{"indication":"Constipation","otherDrugs":[{"name":"bisacodyl","slug":"bisacodyl","company":"Braintree"},{"name":"cholic acid","slug":"cholic-acid","company":"Rtrx"},{"name":"docusate sodium","slug":"docusate-sodium","company":""},{"name":"glycerol","slug":"glycerol","company":"B Braun"}],"globalPrevalence":null}],"mechanism":{"novelty":"First-in-class","modality":"Small Molecule","drugClass":"oxyphenisatine","explanation":"","oneSentence":"","technicalDetail":"OxypHENISATINE is a direct-acting smooth muscle relaxant that may also have a central nervous system component, although the exact mechanism of action is unclear and requires further investigation."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/2038","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=OXYPHENISATINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T02:42:09.685141","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:05:11.315249+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[{"drugName":"bisacodyl","drugSlug":"bisacodyl","fdaApproval":"2004-05-10","relationship":"same-class"},{"drugName":"castor oil","drugSlug":"castor-oil","fdaApproval":"","relationship":"same-class"},{"drugName":"sodium picosulfate","drugSlug":"sodium-picosulfate","fdaApproval":"2012-07-16","relationship":"same-class"}],"genericName":"oxyphenisatine","indications":{"approved":[{"name":"Constipation","source":"DrugCentral","snomedId":14760008,"regulator":"FDA"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"bisacodyl","brandName":"bisacodyl","genericName":"bisacodyl","approvalYear":"2004","relationship":"same-class"},{"drugId":"castor-oil","brandName":"castor oil","genericName":"castor oil","approvalYear":"","relationship":"same-class"},{"drugId":"sodium-picosulfate","brandName":"sodium picosulfate","genericName":"sodium picosulfate","approvalYear":"2012","relationship":"same-class"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"004457","UNII":"3BT0VQG2GQ","CHEBI":"CHEBI:135358","INN_ID":"774","RXNORM":"225825","UMLSCUI":"C0031422","chemblId":"CHEMBL245807","ChEMBL_ID":"CHEMBL245807","KEGG_DRUG":"D08326","DRUGBANK_ID":"DB04823","PUBCHEM_CID":"31315","SNOMEDCT_US":"346604000","MESH_DESCRIPTOR_UI":"D010114"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":9,"therapeuticAreas":["Other"],"atcClassification":{"source":"DrugCentral","atcCode":"A06AB01","allCodes":["A06AB01"]},"biosimilarFilings":[],"recentPublications":[{"date":"2025 Feb","pmid":"39787079","title":"Determination of oxyphenisatine and its total ester derivatives content in fermented green plum by ultra performance liquid chromatography-tandem mass spectrometry.","journal":"Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment"},{"date":"2011 Jul","pmid":"20852860","title":"Novel small molecule drugs inhibit tumor cell metabolism and show potent anti-tumorigenic potential.","journal":"Cancer chemotherapy and pharmacology"},{"date":"1994 Jan","pmid":"8136086","title":"Adverse effects of drugs used in the management of constipation and diarrhoea.","journal":"Drug safety"},{"date":"1982 Apr","pmid":"6285673","title":"The action of six lipid perturbing substances on hormone receptor adenylate cyclase complex in turkey erythrocytes and intestinal mucosa cells.","journal":"Acta pharmacologica et toxicologica"},{"date":"1979 Jun 2","pmid":"386256","title":"[Drug-induced active hepatitis (author's transl)].","journal":"La Nouvelle presse medicale"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Veripaque, also known as oxypHENISATIN, is a small molecule medication. Its exact clinical uses are not specified in the provided facts, but it has been identified by various synonyms.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:05:11.315249+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}